ANI PHARMACEUTICALS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $883.4 | $614.4 | $486.8 | $316.4 | $216.1 |
| Operating income | $111.1 | $0.6 | $47.0 | -$35.3 | -$39.8 |
| Net income | $78.3 | -$18.5 | $18.8 | -$47.9 | -$42.6 |
| Cash Flow Statement | |||||
| Free cash flow | $171.4 | $47.8 | $110.1 | -$40.1 | $0.8 |
| Dividends | $1.2 | $1.6 | $1.6 | $1.6 | $0.2 |
| Share repurchases | $12.2 | $11.0 | $5.0 | $2.0 | $0.9 |
Shares outstanding 23.0M · Free float 63.7%
Annual filing data through FY ended December 31, 2025; float as of September 8, 2026.